Denali Therapeutics Inc. - Common Stock — 재무제표 (NASDAQ:DNLI) | MetaTrader

전체 차트 열기 Full chart

뉴스

Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD?

Denali Therapeutics: 'Strong Buy' On AVLAYAH Approval And End Of 2026 FTD-GRN Data

Leqembi Isn’t Enough To Save Biogen Momentum (NASDAQ:BIIB)

Stocks Settle Higher on Iran Peace Hopes and Tech Strength

Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails

Stocks Climb on US-Iran Peace Hopes and Strength in Chipmakers

Stocks Supported by US-Iran Peace Deal Optimism

DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts Prospects

Denali: The First Commercial Validation Of The Blood-Brain Barrier Platform

DNLI Gains 25.4% Year to Date: Should You Buy, Sell or Hold the Stock?

Denali Solved A Major Challenge In Treating A Rare Genetic Disease. Now, Shares Are Flying.

Denali Therapeutics Inc. (DNLI) Discusses FDA Approval and Commercial Launch Plans for AVLAYAH for Hunter Syndrome - Slideshow (NASDAQ:DNLI) 2026-03-27